<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Glucosamine</strong></td></tr><tr><th>Accession Number</th><td><strong>DB01296</strong>&#160; (EXPT01563)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Glucosamine is commonly used as a treatment for osteoarthritis, although its acceptance as a medical therapy varies. It is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB01296/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB01296/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01296.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01296.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01296.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01296.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB01296.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB01296">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand mixtures</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>3416-24-8</td></tr><tr><th>Weight</th><td>Average: 179.1711<br>Monoisotopic: 179.079372531</td></tr><tr><th>Chemical Formula</th><td>C<sub>6</sub>H<sub>13</sub>NO<sub>5</sub></td></tr><tr><th>InChI Key</th><td>MSWZFWKMSRAUBD-IVMDWMLBSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6?/m1/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol</div></td></tr><tr><th>SMILES</th><td><div class="wrap">N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organooxygen Compounds</td></tr><tr><th>Class</th><td>Carbohydrates and Carbohydrate Conjugates</td></tr><tr><th>Subclass</th><td>Amino Sugars</td></tr><tr><th>Direct parent</th><td>Amino Sugars</td></tr><tr><th>Alternative parents</th><td>Hexoses; Oxanes; Hemiacetals; 1,2-Diols; Secondary Alcohols; 1,2-Aminoalcohols; Polyamines; Primary Alcohols; Monoalkylamines</td></tr><tr><th>Substituents</th><td>monosaccharide; oxane; 1,2-aminoalcohol; secondary alcohol; 1,2-diol; hemiacetal; polyol; ether; polyamine; primary alcohol; primary aliphatic amine; alcohol; amine; primary amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the amino sugars. These are sugars having one alcoholic hydroxy group replaced by an amino group; systematically known as x-amino-x-deoxymonosaccharides.  These compounds do not include Glycosylamines.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pharmacodynamics</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Mechanism of action</th><td>Glucosamine is an amino sugar and a prominent precursor in the biochemical synthesis of glycosylated proteins and lipids. Oral glucosamine is commonly used for the treatment of osteoarthritis. Since glucosamine is a precursor for glycosaminoglycans, and glycosaminoglycans are a major component of joint cartilage, supplemental glucosamine may help to rebuild cartilage and treat arthritis. Its use as a therapy for osteoarthritis appears safe, but there is conflicting evidence as to its effectiveness with more recent studies showing limited to no clinical benefit of use. In the United States, glucosamine is not approved by the Food and Drug Administration for medical use in humans. Since glucosamine is classified as a dietary supplement, safety and formulation are solely the responsibility of the manufacturer; evidence of safety and efficacy is not required as long as it is not advertised as a treatment for a medical condition.</td></tr><tr><th>Absorption</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Affected organisms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Pathways</th><td class="data-table-container"><table class="table table-condensed table-striped" id="pathways"><thead><tr><th>Pathway</th><th>Category</th></tr></thead><tbody><tr><td>Salla Disease/Infantile Sialic Acid Storage Disease</td><td>Disease</td></tr><tr><td>Amino Sugar Metabolism</td><td>Metabolic</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00045?highlight%5Bcompounds%5D%5B%5D=DB01296&amp;highlight%5Bproteins%5D%5B%5D=DB01296">SMP00045</a></td></tr><tr><td>G(M2)-Gangliosidosis: Variant B, Tay-sachs disease</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00534?highlight%5Bcompounds%5D%5B%5D=DB01296&amp;highlight%5Bproteins%5D%5B%5D=DB01296">SMP00534</a></td></tr><tr><td>Tay-Sachs Disease</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00390?highlight%5Bcompounds%5D%5B%5D=DB01296&amp;highlight%5Bproteins%5D%5B%5D=DB01296">SMP00390</a></td></tr><tr><td>Sialuria or French Type Sialuria</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00216?highlight%5Bcompounds%5D%5B%5D=DB01296&amp;highlight%5Bproteins%5D%5B%5D=DB01296">SMP00216</a></td></tr><tr><td>Sjogren Larsson Syndrome</td><td>Disease</td><td><a class="btn btn-default btn-xs" href="http://www.smpdb.ca/view/SMP00217?highlight%5Bcompounds%5D%5B%5D=DB01296&amp;highlight%5Bproteins%5D%5B%5D=DB01296">SMP00217</a></td></tr></tbody></table></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              -
        </td>
        <td>0.8589</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9143</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.8221</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Non-substrate
        </td>
        <td>0.7833</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9452</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.976</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9261</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.8377</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.8469</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.7168</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9503</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9347</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9494</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9115</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9777</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9769</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7558
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9716
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Ready biodegradable 
        </td>
        <td>
            0.8286
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          1.2287 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9659
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.969
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Packagers</th><td><ul><li><a href="http://www.21stcenturyvitamins.com">21st Century Healthcare Inc.</a></li>
<li>Equaline Vitamins</li>
<li><a href="http://www.freedavitamins.com">Freeda Vitamins</a></li>
<li><a href="http://www.janssen-ortho.com">Janssen-Ortho Inc.</a></li>
<li><a href="http://www.leaderpharma.com">LeaderPharma</a></li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.mericon.com">Mericon</a></li>
<li><a href="http://www.nexgenpharma.com">Nexgen Pharma Inc.</a></li>
<li>Professional Co.</li>
<li><a href="http://www.sunmarkbrand.com">Sunmark</a></li>
<li><a href="http://www.walgreens.com">Walgreen Co.</a></li>
<li><a href="http://www.zylera.com">Zylera Pharmaceuticals LLC</a></li></ul></td></tr><tr><th>Dosage forms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td class="data-table-container"><table class="table table-condensed table-striped" id="experimental-properties"><thead><tr><th>Drug</th><th style="width: 75%"></th></tr></thead><tbody><tr><td><a href="/drugs/DB00672">Chlorpropamide</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB01120">Gliclazide</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB00222">Glimepiride</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB01016">Glyburide</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB00331">Metformin</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB00491">Miglitol</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB00731">Nateglinide</a></td><td>Possible hyperglycemia</td></tr><tr><td><a href="/drugs/DB01132">Pioglitazone</a></td><td>Possibly hyperglycemia</td></tr><tr><td><a href="/drugs/DB00912">Repaglinide</a></td><td>Possible hyperglycemia</td></tr></tbody></table></td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>